The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection

European Journal of Immunology

Volumn 44, Issue 6, 2014, Pages 1716-1727

  Berry, Gregory J ^a   Budgeon, Lynn R ^b   Cooper, Timothy K ^b   Christensen, Neil D ^b   Waldner, Hanspeter ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

B lymphocytes; Foxp1; Idd locus 9.3; MicroRNA 34a; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; MICRORNA 34A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DAMAGE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE LOCUS; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

B LYMPHOCYTES; FOXP1; IDD LOCUS 9.3; MICRORNA-34A; TYPE 1 DIABETES;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENETIC LOCI; LYMPHOPOIESIS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MICRORNAS; REPRESSOR PROTEINS;

EID: 84901820464     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344116     Document Type: Article

References (46)

1. Bluestone, J. A., Herold, K. and Eisenbarth, G., Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010. 464: 1293-1300.
2. Anderson, M. S. and Bluestone, J. A., The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 2005. 23: 447-485.
3. Mueller, R., Bradley, L. M., Krahl, T. and Sarvetnick, N., Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 1997. 7: 411-418.
4. Peterson, J. D. and Haskins, K., Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 1996. 45: 328-336.
5. Verdaguer, J., Schmidt, D., Amrani, A., Anderson, B., Averill, N. and Santamaria, P., Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 1997. 186: 1663-1676.
6. Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 1089-1100.
7. Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A. et al., B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new new "speed congenic" stock of NOD.Ig mu null mice. J. Exp. Med. 1996. 184: 2049-2053.
8. Noorchashm, H., Noorchashm, N., Kern, J., Rostami, S. Y., Barker, C. F. and Naji, A., B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997. 46: 941-946.
9. Marino, E., Silveira, P. A., Stolp, J. and Grey, S. T., B cell-directed therapies in type 1 diabetes. Trends Immunol. 2011. 32: 287-294.
10. Hu, C. Y., Rodriguez-Pinto, D., Du, W., Ahuja, A., Henegariu, O., Wong, F. S., Shlomchik, M. J. et al., Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 2007. 117: 3857-3867.
11. Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A. et al., Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N. Engl. J. Med. 2009. 361: 2143-2152.
12. Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H. and Tisch, R. M., B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 1998. 161: 3912-3918.
13. Ridgway, W. M., Peterson, L. B., Todd, J. A., Rainbow, D. B., Healy, B., Burren, O. S. and Wicker, L. S., Gene-gene interactions in the NOD mouse model of type 1 diabetes. Adv. Immunol. 2008. 100: 151-175.
14. Hamilton-Williams, E. E., Wong, S. B., Martinez, X., Rainbow, D. B., Hunter, K. M., Wicker, L. S. and Sherman, L. A., Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells. Diabetes 2010. 59: 1478-1486.
15. Yamanouchi, J., Puertas, M. C., Verdaguer, J., Lyons, P. A., Rainbow, D. B., Chamberlain, G., Hunter, K. M. et al., Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells. Diabetes 2010. 59: 272-281.
16. Chen, Y. G., Scheuplein, F., Osborne, M. A., Tsaih, S. W., Chapman, H. D. and Serreze, D. V., Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice. Diabetes 2008. 57: 3273-3280.
17. Waldner, H., Sobel, R. A., Price, N. and Kuchroo, V. K., The autoimmune diabetes locus Idd9 regulates development of type 1 diabetes by affecting the homing of islet-specific T cells. J. Immunol. 2006. 176: 5455-5462.
18. Lyons, P. A., Hancock, W. W., Denny, P., Lord, C. J., Hill, N. J., Armitage, N., Siegmund, T. et al., The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 2000. 13: 107-115.
19. Kachapati, K., Adams, D. E., Wu, Y., Steward, C. A., Rainbow, D. B., Wicker, L. S., Mittler, R. S. et al., The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model. J. Immunol. 2012. 189: 5001-5015.
20. Rao, D. S., O'Connell, R. M., Chaudhuri, A. A., Garcia-Flores, Y., Geiger, T. L. and Baltimore, D., MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010. 33: 48-59.
21. Hu, H., Wang, B., Borde, M., Nardone, J., Maika, S., Allred, L., Tucker, P. W. et al., Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 2006. 7: 819-826.
22. Cannons, J. L., Chamberlain, G., Howson, J., Smink, L. J., Todd, J. A., Peterson, L. B., Wicker, L. S. et al., Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. J. Autoimmun. 2005. 25: 13-20.
23. Hoglund, P., Mintern, J., Waltzinger, C., Heath, W., Benoist, C. and Mathis, D., Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 1999. 189: 331-339.
24. Gagnerault, M. C., Luan, J. J., Lotton, C. and Lepault, F., Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 2002. 196: 369-377.
25. Loder, F., Mutschler, B., Ray, R., Paige, C., Sideras, P., Torres, R., Lamers, M. et al., B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999. 190: 75-89.
26. Carsetti, R., Rosado, M. M. and Wardmann, H., Peripheral development of B cells in mouse and man. Immunol. Rev. 2004. 197: 179-191.
27. Allman, D. and Pillai, S., Peripheral B cell subsets. Curr. Opin. Immunol. 2008. 20: 149-157.
28. Quinn, W. J., 3rd, Noorchashm, N., Crowley, J. E., Reed, A. J., Noorchashm, H., Naji, A. and Cancro, M. P., Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J. Immunol. 2006. 176: 7159-7164.
29. Srivastava, B., Quinn, W. J., 3rd, Hazard, K., Erikson, J. and Allman, D., Characterization of marginal zone B cell precursors. J. Exp. Med. 2005. 202: 1225-1234.
30. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa, K., Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 1991. 173: 1213-1225.
31. Bartel, D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009. 136: 215-233.
32. Vergoulis, T., Vlachos, I. S., Alexiou, P., Georgakilas, G., Maragkakis, M., Reczko, M., Gerangelos, S. et al., TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res. 2012. 40: D222-D229.
33. Janeway, C. A., Jr., Ron, J. and Katz, M. E., The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 1987. 138: 1051-1055.
34. Judkowski, V., Pinilla, C., Schroder, K., Tucker, L., Sarvetnick, N. and Wilson, D. B., Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 2001. 166: 908-917.
35. Bouaziz, J. D., Yanaba, K., Venturi, G. M., Wang, Y., Tisch, R. M., Poe, J. C. and Tedder, T. F., Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl. Acad. Sci. U. S. A. 2007. 104: 20878-20883.
36. Sagardoy, A., Martinez-Ferrandis, J. I., Roa, S., Bunting, K. L., Aznar, M. A., Elemento, O., Shaknovich, R. et al., Downregulation of FOXP1 is required during germinal center B-cell function. Blood 2013. 121: 4311-4320.
37. Chang, T. C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G. et al., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007. 26: 745-752.
38. Irie, J., Wu, Y., Sass, D. A. and Ridgway, W. M., Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. Immunogenetics 2006. 58: 9-14.
39. Mayne, C. G., Amanna, I. J., Nashold, F. E. and Hayes, C. E., Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur. J. Immunol. 2008. 38: 587-598.
40. Falcone, M., Lee, J., Patstone, G., Yeung, B. and Sarvetnick, N., B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 1998. 161: 1163-1168.
41. Lund, F. E. and Randall, T. D., Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat. Rev. Immunol. 2010. 10: 236-247.
42. Wong, F. S., Wen, L., Tang, M., Ramanathan, M., Visintin, I., Daugherty, J., Hannum, L. G. et al., Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004. 53: 2581-2587.
43. Marino, E., Batten, M., Groom, J., Walters, S., Liuwantara, D., Mackay, F. and Grey, S., Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 2008. 57: 395-404.
44. Serreze, D. V., Chapman, H. D., Niens, M., Dunn, R., Kehry, M. R., Driver, J. P., Haller, M. et al., Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies. Diabetes 2011. 60: 2914-2921.
45. Stolp, J., Chen, Y. G., Cox, S. L., Henck, V., Zhang, W., Tsaih, S. W., Chapman, H. et al., Subcongenic analyses reveal complex interactions between distal chromosome 4 genes controlling diabetogenic B cells and CD4 T cells in nonobese diabetic mice. J. Immunol. 2012. 189: 1406-1417.
46. Livak, K. J. and Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001. 25: 402-408.